As of 2026-03-17, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is (0.24) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.80 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -130.2%.
The range of the Relative Valuation is (0.19) - (0.29) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.2x - 1.9x | 1.6x |
| Forward P/E multiples | 1.2x - 1.9x | 1.6x |
| Fair Price | (0.19) - (0.29) | (0.24) |
| Upside | -124.1% - -136.2% | -130.2% |
| Date | P/E |
| 2026-03-13 | -4.95 |
| 2026-03-12 | -5.14 |
| 2026-03-11 | -5.52 |
| 2026-03-10 | -5.65 |
| 2026-03-09 | -5.52 |
| 2026-03-06 | -5.27 |
| 2026-03-05 | -5.39 |
| 2026-03-04 | -5.72 |
| 2026-03-03 | -5.59 |
| 2026-03-02 | -5.65 |
| 2026-02-27 | -5.78 |
| 2026-02-26 | -6.10 |
| 2026-02-25 | -5.72 |
| 2026-02-24 | -5.84 |
| 2026-02-23 | -6.04 |
| 2026-02-20 | -5.78 |
| 2026-02-19 | -5.52 |
| 2026-02-18 | -5.52 |
| 2026-02-17 | -5.27 |
| 2026-02-13 | -5.33 |
| 2026-02-12 | -4.88 |
| 2026-02-11 | -4.88 |
| 2026-02-10 | -5.07 |
| 2026-02-09 | -5.14 |
| 2026-02-06 | -5.27 |
| 2026-02-05 | -5.27 |
| 2026-02-04 | -5.52 |
| 2026-02-03 | -5.59 |
| 2026-02-02 | -5.78 |
| 2026-01-30 | -5.65 |
| 2026-01-29 | -5.72 |
| 2026-01-28 | -5.72 |
| 2026-01-27 | -5.65 |
| 2026-01-26 | -5.78 |
| 2026-01-23 | -6.04 |
| 2026-01-22 | -6.23 |
| 2026-01-21 | -5.91 |
| 2026-01-20 | -5.78 |
| 2026-01-19 | -5.97 |
| 2026-01-16 | -6.10 |
| 2026-01-15 | -5.97 |
| 2026-01-14 | -6.04 |
| 2026-01-13 | -6.10 |
| 2026-01-12 | -6.04 |
| 2026-01-09 | -6.04 |
| 2026-01-08 | -6.04 |
| 2026-01-07 | -6.10 |
| 2026-01-06 | -5.97 |
| 2026-01-05 | -6.23 |
| 2026-01-02 | -6.42 |